Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Swedish BioFINDER - Preclinical AD Study

NCT06121544 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT06121544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Swedish BioFINDER - Preclinical AD Study
Lead sponsor
Skane University Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2022
Completion date
December 31, 2026
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment, mild dementia